Table 2

Normal values of diagnostic markers in study
Diagnostic markers Normal value (reference value) Neoplasia (N=63) JIA (N=71)
Lower values or presence (n/N; %) Normal values (n/N; %) Higher values or positivity (n/N; %) Lower values or present (n/N; %) Normal values (n/N; %) Higher values or positivity (n/N; %)
WBC count 4-10 × 109/L 11/60; 18.3% 27/60; 45% 22/60; 36.7% 3/68; 4.4% 35/68; 51.5% 30/68; 44.1%
Neutrophil count 1 × 109/L 25/55; 45.5% 30/55; 54.5% 0/55; 0% 2/61; 3.3% 59/61; 96.7% 0/61; 0%
Platelet count 150-300 × 109/L 34/60; 56.7% 13/60; 21.7% 13/60; 21.7% 2/68; 2.9% 17/68; 25% 49/68; 72.1%
Hemoglobin (Hgb) ≥10 gr/dl 34/60; 56.7% 26/60; 43.3% NA 62/68; 91.2% 6/68; 8.8% NA
Lactic dehydrogenase (LDH) <500 IU/L NA 7/58; 12.1% 51/58; 87.9% NA 16/49; 32.7% 33/49; 67.3%
Erythrocyte sedimentation rate (ESR) <20 mm/h NA 4/37; 10.8% 33/37; 89.2% NA 14/68; 20.6% 54/68; 79.4%
C-reactive protein (CRP) <1 mg/dl NA 13/52; 25% 39/52; 75% NA 14/61; 23% 47/61; 77%
Antinuclear antibody (ANA) ≥1:80 NA 16/19; 84.2% 3/19; 15.8% NA 30/62; 48.4% 32/62; 51.6%
IgG 751–1560 mg/dl 9/51; 17.6% 35/51; 68.6% 7/51; 13.7% 2/57; 3.5% 35/57; 61.4% 20/57; 35.1%
IgM 46–304 mg/dl 4/51; 7.8% 47/51; 92.2% 0/51; 0% 1/57; 1.8% 53/57; 93% 3/57; 5.3%
IgA 82–453 mg/dl 17/51; 33.3% 33/51; 64.7% 1/51; 2% 6/57; 10.5% 49/57; 86% 2/57; 3.5%
C3 79–152 mg/dl 1/36; 2.8% 14/36; 38.9% 21/36; 58.3% 3/54; 5.6% 29/54; 53.7% 22/54; 40.7%
C4 16–38 mg/dl 1/36; 2.8% 19/36; 52.8% 16/36; 44.4% 4/53; 7.5% 44/53; 83% 5/53; 9.4%
Anti-EBV IgM Negative NA 37/44; 84.1% 7/44; 15.9% NA 13/14; 92.9% 1/14; 7.1%
Anti-EBV IgG Negative NA 11/44; 25% 33/44; 75% NA 7/15; 46.7% 8/15; 53.3%
Anti-EA EBV IgG Negative NA 21/35; 60% 14/35; 40% NA 10/10; 100% 0/10; 0%
Anti-CMV IgM Negative NA 32/34; 94.1% 2/34; 5.9% NA 8/10; 80% 2/10; 20%
Anti-CMV IgG Negative NA 9/33; 27.3% 24/33; 72.7% NA 8/10; 80% 2/10; 20%

Agodi et al.

Agodi et al. BMC Pediatrics 2013 13:15   doi:10.1186/1471-2431-13-15

Open Data